manufacturing

News

Generic drugmaker Hikma pledges $1bn in US investment

With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.

News

Manufacturing issues scupper Savara's lead drug filing

Savara shares are pummelled after the FDA says it cannot accept a filing for lead drug Molbreevi, but it is still hopeful of an approval in 2026.

News

Sanofi pledges a $20 billion investment programme in the US

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.

R&D

For cell therapies, raw material quality hinges on the human...

When it comes to cell-based therapy manufacturing, the concept of quality management carries important distinctions from more traditional therapeutics production.

News

Gilead Sciences' chief executive Daniel O'Day

Gilead ups its US investment plans by $11 billion

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US.

News

FDA ramps up unannounced inspections of foreign facilities

Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.

Generic drugmaker Hikma pledges $1bn in US investment

Manufacturing issues scupper Savara's lead drug filing

Sanofi pledges a $20 billion investment programme in the US

For cell therapies, raw material quality hinges on the human...

Gilead ups its US investment plans by $11 billion

FDA ramps up unannounced inspections of foreign facilities

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

manufacturing

Editor's Picks